![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: IL13RA1 |
Gene summary for IL13RA1 |
![]() |
Gene information | Species | Human | Gene symbol | IL13RA1 | Gene ID | 3597 |
Gene name | interleukin 13 receptor subunit alpha 1 | |
Gene Alias | CD213A1 | |
Cytomap | Xq24 | |
Gene Type | protein-coding | GO ID | GO:0007154 | UniProtAcc | P78552 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
3597 | IL13RA1 | HTA11_78_2000001011 | Human | Colorectum | AD | 1.98e-04 | 2.86e-01 | -0.1088 |
3597 | IL13RA1 | HTA11_347_2000001011 | Human | Colorectum | AD | 9.23e-11 | 4.14e-01 | -0.1954 |
3597 | IL13RA1 | HTA11_411_2000001011 | Human | Colorectum | SER | 2.27e-02 | 5.71e-01 | -0.2602 |
3597 | IL13RA1 | HTA11_99999965104_69814 | Human | Colorectum | MSS | 2.01e-08 | 5.20e-01 | 0.281 |
3597 | IL13RA1 | A015-C-203 | Human | Colorectum | FAP | 1.08e-05 | -1.27e-01 | -0.1294 |
3597 | IL13RA1 | A001-C-108 | Human | Colorectum | FAP | 7.08e-03 | -1.28e-01 | -0.0272 |
3597 | IL13RA1 | A015-C-106 | Human | Colorectum | FAP | 6.69e-05 | -1.38e-01 | -0.0511 |
3597 | IL13RA1 | A015-C-104 | Human | Colorectum | FAP | 4.83e-08 | -1.95e-01 | -0.1899 |
3597 | IL13RA1 | A002-C-016 | Human | Colorectum | FAP | 2.00e-02 | -7.58e-02 | 0.0521 |
3597 | IL13RA1 | A001-C-203 | Human | Colorectum | FAP | 1.68e-04 | -1.19e-01 | -0.0481 |
3597 | IL13RA1 | A002-C-116 | Human | Colorectum | FAP | 1.82e-07 | -9.78e-02 | -0.0452 |
3597 | IL13RA1 | F034 | Human | Colorectum | FAP | 1.10e-04 | -1.40e-01 | -0.0665 |
3597 | IL13RA1 | LZE20T | Human | Esophagus | ESCC | 2.42e-02 | 3.22e-01 | 0.0662 |
3597 | IL13RA1 | LZE24T | Human | Esophagus | ESCC | 8.75e-27 | 8.51e-01 | 0.0596 |
3597 | IL13RA1 | P1T-E | Human | Esophagus | ESCC | 6.72e-11 | 8.50e-01 | 0.0875 |
3597 | IL13RA1 | P2T-E | Human | Esophagus | ESCC | 5.86e-16 | 3.19e-01 | 0.1177 |
3597 | IL13RA1 | P4T-E | Human | Esophagus | ESCC | 3.01e-11 | 2.58e-01 | 0.1323 |
3597 | IL13RA1 | P5T-E | Human | Esophagus | ESCC | 6.90e-11 | 2.15e-01 | 0.1327 |
3597 | IL13RA1 | P8T-E | Human | Esophagus | ESCC | 3.08e-30 | 7.17e-01 | 0.0889 |
3597 | IL13RA1 | P9T-E | Human | Esophagus | ESCC | 6.18e-17 | 4.77e-01 | 0.1131 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00192214 | Oral cavity | OSCC | cytokine-mediated signaling pathway | 222/7305 | 472/18723 | 2.02e-04 | 1.35e-03 | 222 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
IL13RA1 | SNV | Missense_Mutation | rs376481841 | c.205N>A | p.His69Asn | p.H69N | P78552 | protein_coding | tolerated(0.13) | benign(0.243) | TCGA-B5-A11E-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
IL13RA1 | SNV | Missense_Mutation | c.727N>A | p.Leu243Ile | p.L243I | P78552 | protein_coding | tolerated(0.8) | benign(0.205) | TCGA-B5-A11E-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
IL13RA1 | SNV | Missense_Mutation | rs142037578 | c.1240N>A | p.Asp414Asn | p.D414N | P78552 | protein_coding | tolerated(0.37) | probably_damaging(0.965) | TCGA-B5-A1MR-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
IL13RA1 | SNV | Missense_Mutation | c.753N>T | p.Gln251His | p.Q251H | P78552 | protein_coding | tolerated(0.07) | benign(0.087) | TCGA-BS-A0UF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
IL13RA1 | SNV | Missense_Mutation | novel | c.536N>G | p.Glu179Gly | p.E179G | P78552 | protein_coding | tolerated(0.05) | benign(0.251) | TCGA-E6-A1LX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
IL13RA1 | SNV | Missense_Mutation | novel | c.866N>T | p.Arg289Ile | p.R289I | P78552 | protein_coding | tolerated(0.44) | benign(0.025) | TCGA-E6-A1LX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
IL13RA1 | SNV | Missense_Mutation | novel | c.308G>A | p.Ser103Asn | p.S103N | P78552 | protein_coding | tolerated(0.49) | benign(0.005) | TCGA-EO-A22U-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
IL13RA1 | SNV | Missense_Mutation | novel | c.674G>A | p.Arg225His | p.R225H | P78552 | protein_coding | tolerated(0.64) | benign(0) | TCGA-EO-A22U-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
IL13RA1 | SNV | Missense_Mutation | novel | c.1118N>G | p.Ile373Ser | p.I373S | P78552 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-EO-A3B0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
IL13RA1 | SNV | Missense_Mutation | novel | c.303N>T | p.Gln101His | p.Q101H | P78552 | protein_coding | deleterious(0) | probably_damaging(0.971) | TCGA-EY-A2OQ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
3597 | IL13RA1 | EXTERNAL SIDE OF PLASMA MEMBRANE, KINASE, DRUGGABLE GENOME | CINTREDEKIN BESUDOTOX | |||
3597 | IL13RA1 | EXTERNAL SIDE OF PLASMA MEMBRANE, KINASE, DRUGGABLE GENOME | AER001,AEROVANT |
Page: 1 |